1. Federal Food, Drug, and Cosmetic Act. Title 21, Chapter 9, Section 505.
2. Benefit-Risk Balance for Marketed Drugs: Evaluating Safety. Report of CIOMS Working Group IV. CIOMS: Geneva, 1998.
3. Contraindicated Use of Cisapride
4. eds. To Err is Human: Building a Safer Health System. Institute of Medicine: Washington DC; 1999.